P Stijnen1, B Brouwers1, E Dirkx1, B Ramos-Molina1, L Van Lommel2, F Schuit2, L Thorrez3, J Declercq1, J W M Creemers1. 1. Laboratory for Biochemical Neuroendocrinology, Department of Human Genetics, KU Leuven, Leuven, Belgium. 2. Gene Expression Unit, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium. 3. Department of Development and Regeneration, KU Leuven, Leuven, Belgium.
Abstract
BACKGROUND: The proprotein convertase 1/3 (PC1/3), encoded by proprotein convertase subtilisin/kexin type 1 (PCSK1), cleaves and hence activates several orexigenic and anorexigenic proproteins. Congenital inactivation of PCSK1 leads to obesity in human but not in mice. However, a mouse model harboring the hypomorphic mutation N222D is obese. It is not clear why the mouse models differ in phenotype. METHODS: Gene expression analysis was performed with pancreatic islets from Pcsk1(N222D/N222D) mice. Subsequently, biosynthesis, maturation, degradation and activity were studied in islets, pituitary, hypothalamus and cell lines. Coimmunoprecipitation of PC1/3-N222D and human PC1/3 variants associated with obesity with the endoplasmic reticulum (ER) chaperone BiP was studied in cell lines. RESULTS: Gene expression analysis of islets of Pcsk1(N222D/N222D) mice showed enrichment of gene sets related to the proteasome and the unfolded protein response. Steady-state levels of PC1/3-N222D and in particular the carboxy-terminally processed form were strongly reduced in islets, pituitary and hypothalamus. However, impairment of substrate cleavage was tissue dependent. Proinsulin processing was drastically reduced, while processing of proopiomelanocortin (POMC) to adrenocorticotropic hormone (ACTH) in pituitary was only mildly impaired. Growth hormone expression and IGF-1 levels were normal, indicating near-normal processing of hypothalamic proGHRH. PC1/3-N222D binds to BiP and is rapidly degraded by the proteasome. Analysis of human PC1/3 obesity-associated mutations showed increased binding to BiP and prolonged intracellular retention for all investigated mutations, in particular for PC1/3-T175M, PC1/3-G226R and PC1/3-G593R. CONCLUSIONS: This study demonstrates that the hypomorphic mutation in Pcsk1(N222D) mice has an effect on catalytic activity in pancreatic islets, pituitary and hypothalamus. Reduced substrate processing activity in Pcsk1(N222D/N222D) mice is due to enhanced degradation in addition to reduced catalytic activity of the mutant. PC1/3-N222D binds to BiP, suggesting impaired folding and reduced stability. Enhanced BiP binding is also observed in several human obesity-associated PC1/3 variants, suggesting a common mechanism.
BACKGROUND: The proprotein convertase 1/3 (PC1/3), encoded by proprotein convertase subtilisin/kexin type 1 (PCSK1), cleaves and hence activates several orexigenic and anorexigenic proproteins. Congenital inactivation of PCSK1 leads to obesity in human but not in mice. However, a mouse model harboring the hypomorphic mutation N222D is obese. It is not clear why the mouse models differ in phenotype. METHODS: Gene expression analysis was performed with pancreatic islets from Pcsk1(N222D/N222D) mice. Subsequently, biosynthesis, maturation, degradation and activity were studied in islets, pituitary, hypothalamus and cell lines. Coimmunoprecipitation of PC1/3-N222D and humanPC1/3 variants associated with obesity with the endoplasmic reticulum (ER) chaperone BiP was studied in cell lines. RESULTS: Gene expression analysis of islets of Pcsk1(N222D/N222D) mice showed enrichment of gene sets related to the proteasome and the unfolded protein response. Steady-state levels of PC1/3-N222D and in particular the carboxy-terminally processed form were strongly reduced in islets, pituitary and hypothalamus. However, impairment of substrate cleavage was tissue dependent. Proinsulin processing was drastically reduced, while processing of proopiomelanocortin (POMC) to adrenocorticotropic hormone (ACTH) in pituitary was only mildly impaired. Growth hormone expression and IGF-1 levels were normal, indicating near-normal processing of hypothalamic proGHRH. PC1/3-N222D binds to BiP and is rapidly degraded by the proteasome. Analysis of humanPC1/3obesity-associated mutations showed increased binding to BiP and prolonged intracellular retention for all investigated mutations, in particular for PC1/3-T175M, PC1/3-G226R and PC1/3-G593R. CONCLUSIONS: This study demonstrates that the hypomorphic mutation in Pcsk1(N222D) mice has an effect on catalytic activity in pancreatic islets, pituitary and hypothalamus. Reduced substrate processing activity in Pcsk1(N222D/N222D) mice is due to enhanced degradation in addition to reduced catalytic activity of the mutant. PC1/3-N222D binds to BiP, suggesting impaired folding and reduced stability. Enhanced BiP binding is also observed in several humanobesity-associated PC1/3 variants, suggesting a common mechanism.
Authors: Pieter Stijnen; Krizia Tuand; Tibor V Varga; Paul W Franks; Bert Aertgeerts; John W M Creemers Journal: Am J Epidemiol Date: 2014-10-29 Impact factor: 4.897
Authors: Chong Wee Liew; Anke Assmann; Andrew T Templin; Jeffrey C Raum; Kathryn L Lipson; Sindhu Rajan; Guifen Qiang; Jiang Hu; Dan Kawamori; Iris Lindberg; Louis H Philipson; Nahum Sonenberg; Allison B Goldfine; Doris A Stoffers; Raghavendra G Mirmira; Fumihiko Urano; Rohit N Kulkarni Journal: Proc Natl Acad Sci U S A Date: 2014-05-19 Impact factor: 11.205
Authors: Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov Journal: Proc Natl Acad Sci U S A Date: 2005-09-30 Impact factor: 11.205
Authors: Donalyn Scheuner; Dirk Vander Mierde; Benbo Song; Daisy Flamez; John W M Creemers; Katsura Tsukamoto; Mark Ribick; Frans C Schuit; Randal J Kaufman Journal: Nat Med Date: 2005-06-26 Impact factor: 53.440
Authors: Xiaorong Zhu; An Zhou; Arunangsu Dey; Christina Norrbom; Raymond Carroll; Chunling Zhang; Virginie Laurent; Iris Lindberg; Randi Ugleholdt; Jens J Holst; Donald F Steiner Journal: Proc Natl Acad Sci U S A Date: 2002-07-26 Impact factor: 11.205
Authors: Eva Corpeleijn; Liselotte Petersen; Claus Holst; Wim H Saris; Arne Astrup; Dominique Langin; Ian MacDonald; J Alfredo Martinez; Jean-Michel Oppert; Jan Polak; Oluf Pedersen; Philippe Froguel; Peter Arner; Thorkild I A Sørensen; Ellen E Blaak Journal: Obesity (Silver Spring) Date: 2009-10-29 Impact factor: 5.002
Authors: Yogikala Prabhu; Elias H Blanco; Ming Liu; Juan R Peinado; Matthew C Wheeler; Nicholas Gekakis; Peter Arvan; Iris Lindberg Journal: Endocrinology Date: 2014-05-14 Impact factor: 4.736
Authors: Lindsay A Pickett; Michael Yourshaw; Valeria Albornoz; Zijun Chen; R Sergio Solorzano-Vargas; Stanley F Nelson; Martín G Martín; Iris Lindberg Journal: PLoS One Date: 2013-01-28 Impact factor: 3.240
Authors: Alexandra Winters; Bruno Ramos-Molina; Timothy S Jarvela; Laura Yerges-Armstrong; Toni I Pollin; Iris Lindberg Journal: Diabetes Res Clin Pract Date: 2017-07-03 Impact factor: 5.602
Authors: David R Powell; Deon D Doree; Christopher M DaCosta; Kenneth A Platt; Gwenn M Hansen; Isaac van Sligtenhorst; Zhi-Ming Ding; Jean-Pierre Revelli; Robert Brommage Journal: Diabetes Metab Syndr Obes Date: 2020-07-27 Impact factor: 3.168
Authors: Laetitia Aerts; Nathalie A Terry; Nina N Sainath; Clarivet Torres; Martín G Martín; Bruno Ramos-Molina; John W Creemers Journal: Genes (Basel) Date: 2021-05-10 Impact factor: 4.096